Tracey D Moore, RN | |
1124 Cameron St, Ansley, NE 68814-0370 | |
(308) 935-1121 | |
(308) 935-9103 |
Full Name | Tracey D Moore |
---|---|
Gender | Female |
Speciality | Registered Nurse - General Practice |
Location | 1124 Cameron St, Ansley, Nebraska |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306491311 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WG0000X | Registered Nurse - General Practice | 56186 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Tracey D Moore, RN Po Box 370, Ansley, NE 68814-0370 Ph: (308) 935-1121 | Tracey D Moore, RN 1124 Cameron St, Ansley, NE 68814-0370 Ph: (308) 935-1121 |
News Archive
An innovative strategy called Teens Against Tobacco Use showed promise as an effective strategy to deter tobacco use in middle and high school students, according to a research study by The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
Mylan Inc. today announced that it has filed suit against the U.S. Food and Drug Administration, challenging the agency's decision regarding generic drug marketing exclusivity on Celecoxib Capsules, the generic version of Pfizer's Celebrex.
Will McKitterick, a research assistant with the Center for Global Development (CGD), in this "Rethinking U.S. Foreign Assistance" blog post summarizes Secretary of State Hillary Clinton's "grueling marathon of Congressional committee hearings in defense of the FY2013 international affairs budget request."
A new study by researchers at the UCLA Jonsson Comprehensive Cancer Center has identified a novel combination therapy to potentially help overcome resistance to immunotherapy in people diagnosed with advanced lung cancer.
The leukemia stem cell-the root cause of all acute leukemias- represents a small population of cells in patients that are difficult to eliminate with standard treatments available today. Though current chemotherapy can produce temporary remission in leukemia survivors, they remain at risk of experiencing a recurrence and dying from the disease.
› Verified 7 days ago